FRRS1: A Potential Drug Target and Biomarker (G391059)

Target Name: FRRS1

NCBI ID: G391059

FRRS1

FRRS1: A Potential Drug Target and Biomarker

FRRS1 (Stromal cell derived factor receptor 2 homolog) is a protein that is expressed in a variety of tissues throughout the body, including the heart, kidneys, liver, and pancreas. It is a member of the tyrosine kinase family, which includes proteins that are involved in the regulation of cell growth, differentiation, and survival.

FRRS1 has been identified as a potential drug target due to its involvement in several cellular processes that are important for human health. One of its main functions is to regulate the growth and differentiation of heart cells, which is critical for maintaining the structure and function of the heart.

FRRS1 has also been shown to play a role in the regulation of inflammation and immune cell function. It has been shown to interact with several different types of immune cells, including T cells, B cells, and natural killer cells. This suggests that it may be a useful target for drugs that are aimed at treating autoimmune diseases.

In addition to its potential drug-targeting properties, FRRS1 has also been shown to have several potential biomarker properties. For example, it has been shown to be upregulated in a variety of diseases, including cancer, fibrosis, and autoimmune diseases. This suggests that it may be a useful biomarker for these conditions.

Another potential use for FRRS1 as a drug target is its role in the regulation of cell survival. Several studies have shown that FRRS1 plays a role in the regulation of cell survival by controlling the activity of several different signaling pathways. This suggests that it may be a useful target for drugs that are aimed at extending the lifespan of cells.

Overall, FRRS1 is a protein that has the potential to be a drug target or biomarker due to its involvement in several cellular processes that are important for human health. Further research is needed to fully understand its role and potential uses.

Protein Name: Ferric Chelate Reductase 1

Functions: Ferric-chelate reductases reduce Fe(3+) to Fe(2+) before its transport from the endosome to the cytoplasm

The "FRRS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FRRS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets